When Ducks Stop Laying, Their Livers Pay a Metabolic Price, Study Finds

For a laying hen or duck, the liver is far more than a metabolic workhorse; it is the biochemical factory that manufactures the yolk precursors destined for the ovary. When egg production winds down, that factory does not simply idle. A new study published in BMC Genomics suggests that when ducks cease laying, their livers accumulate fat, show signs of inflammation, and undergo sweeping changes in gene expression and lipid composition that mirror, in some respects, the metabolic dysfunction seen in fatty liver disease. The research, led by Ning Zhou and Kaiqi Weng with colleagues at the Zhejiang Academy of Agricultural Sciences and collaborating institutions in China, offers one of the most detailed multi-omics portraits to date of what happens to avian hepatic metabolism as reproductive life draws to a close.

The research team compared two groups of late-laying ducks: those still producing eggs, designated the egg-laying phase, and those that had stopped, designated the ceased-laying phase. Because birds route virtually all yolk lipid synthesis through the liver, the organ is exquisitely sensitive to shifts in reproductive status. In mammals, the adipose tissue and liver share the burden of lipid handling, but in laying birds the liver takes on an extraordinary load, synthesizing and exporting vast quantities of very low density lipoprotein and vitellogenin to supply the developing ovarian follicles. When the ovary regresses and that demand evaporates, the question becomes what happens to the liver’s lipid-processing machinery, and whether it recalibrates gracefully or slips into dysfunction.

The first answer came from simple anatomy and biochemistry. The liver index, a measure of liver weight relative to body weight, was significantly higher in the ceased-laying ducks than in their still-laying counterparts. Histopathological examination of liver tissue revealed greater infiltration of inflammatory cells and a marked accumulation of lipid droplets in the ceased layers. These structural changes were accompanied by shifts in serum chemistry: levels of aspartate aminotransferase, an enzyme that leaks into the bloodstream when liver cells are damaged, were elevated in the ceased-laying birds, as were total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol. Together, these findings paint a picture of a liver under strain, storing fat it can no longer efficiently export and showing biochemical signatures consistent with hepatic injury.

To understand the molecular underpinnings of these changes, the researchers turned to transcriptomics, the systematic measurement of gene activity across the liver. The analysis identified a substantial set of differentially expressed genes between the two groups, and when those genes were mapped onto known biological pathways, several functional themes emerged. The affected pathways included the adipocytokine signaling pathway, which links fat tissue-derived hormones to hepatic metabolism; the PPAR signaling pathway, a master regulator of fatty acid oxidation and lipid transport; the insulin signaling pathway, which governs nutrient storage and glucose-lipid partitioning; and steroid hormone biosynthesis, the biochemical route by which cholesterol is converted into reproductive hormones.

The involvement of these particular pathways makes biological sense in the context of ovarian regression. The PPAR family of nuclear receptors sits at the crossroads of lipid uptake, synthesis, and breakdown, and its dysregulation is a hallmark of hepatic steatosis in many species. Adipocytokines such as adiponectin and leptin modulate insulin sensitivity and fatty acid metabolism in the liver, and their signaling networks are known to shift when energy balance changes. The appearance of steroid hormone biosynthesis among the enriched pathways underscores the intimate two-way conversation between the liver and the ovary: the liver supplies the cholesterol substrate for hormone synthesis, and the ovary’s hormonal output feeds back on hepatic gene expression. When the ovary regresses, that feedback loop is severed, and the liver’s transcriptional program appears to drift accordingly.

Gene expression, however, tells only half the story. To capture the actual chemical end points of the altered metabolic program, the team performed lipidomic profiling, cataloguing the lipid species present in the livers of both groups. The differential lipids fell into four major categories: glycerophospholipids, the phosphorus-containing molecules that form cellular membranes; glycerolipids, which include triglycerides and other storage fats; sphingolipids, a class of structural and signaling lipids; and fatty acyls, the free fatty acids and their derivatives. The redistribution of lipid species across these classes indicates that ceasing egg production does not simply cause a uniform buildup of fat, but rather a wholesale reorganization of the liver’s lipid inventory, affecting membrane composition and signaling molecules as well as storage triglycerides.

The most ambitious part of the study was the integration of the two data layers. By combining the transcriptomic and lipidomic datasets, the researchers identified coordinated changes linking specific gene-expression shifts to specific lipid alterations. Four metabolic axes stood out: the adipocytokine signaling pathway, arachidonic acid metabolism, glycerophospholipid metabolism, and glycerolipid metabolism. Arachidonic acid is an omega-6 polyunsaturated fatty acid that serves as the precursor for eicosanoids, potent inflammatory mediators, so its altered metabolism dovetails with the histological observation of inflammatory cell infiltration in the ceased-laying livers. The concurrent disruption of glycerophospholipid and glycerolipid metabolism suggests that both the membrane lipid pool and the storage lipid pool are remodeled simultaneously, consistent with the visible accumulation of lipid droplets in the tissue.

What emerges from the integrated analysis is a coherent mechanistic narrative. As the ovary regresses, the hepatic demand for yolk precursor synthesis collapses, but the liver’s lipid import and synthesis machinery does not shut down in lockstep. Genes governing fatty acid handling, insulin responsiveness, and inflammatory signaling shift their activity, and the lipidome follows, with triglycerides and other lipids accumulating in droplets while phospholipid and fatty acid profiles diverge from the laying state. The elevated serum cholesterol fractions and liver enzymes in the ceased-laying ducks suggest that this hepatic disarray has systemic consequences, extending beyond the organ itself into circulating lipid transport and markers of cell damage.

The practical implications reach into poultry science and agriculture. Ducks are an economically important egg-laying species, and the late-laying period, when production declines and birds approach the end of their productive cycle, represents a management challenge. If hepatic metabolic disorder accompanies ovarian regression, it may affect bird health, welfare, and the economics of extended laying cycles. The differentially expressed genes and lipid metabolites identified in this study provide a molecular toolkit that breeders and nutritionists could potentially use to monitor hepatic status in aging flocks, or to design dietary interventions that ease the liver’s transition out of its egg-production mode. The study was supported by the National Natural Science Foundation of China, the China Agriculture Research System, and the Yangzhou Municipal Science and Technology Plan Project.

Beyond its agricultural relevance, the work speaks to a broader biological question: how the liver adapts, or fails to adapt, when a tissue’s primary metabolic export demand disappears. In laying birds, the liver-ovary axis is an extreme example of a reproductive-metabolic coupling that also exists, in modified form, in mammals during pregnancy and lactation. Understanding how the avian liver copes with the withdrawal of that demand, and which genes and lipids mark the transition, may illuminate general principles of hepatic plasticity and vulnerability. The authors caution that their findings identify correlations between the altered gene and lipid profiles and the modified hepatic lipid status concurrent with ovarian regression; establishing causation and testing interventions will be the work of future studies. For now, the study stands as a detailed molecular snapshot of a metabolic crossroads, capturing the moment when a duck’s liver, built for the extraordinary demands of egg production, confronts their sudden end.

Subject of Research: Hepatic lipid metabolism changes associated with ovarian regression in late-laying ducks

Article Title: Transcriptomic and lipidomic analysis reveal hepatic metabolic disorders associated with ovarian regression in late-laying ducks

Article References: Zhou, N., Weng, K., Liu, J., Lu, L., Xu, W., Zeng, T., Chen, L., Tian, Y., Zhang, Y., & Gu, T. (2026). Transcriptomic and lipidomic analysis reveal hepatic metabolic disorders associated with ovarian regression in late-laying ducks. BMC Genomics. https://doi.org/10.1186/s12864-026-13441-z

Image Credits: AI Generated

DOI: 10.1186/s12864-026-13441-z

Keywords: ducks, liver, ovarian regression, lipid metabolism, transcriptomics, lipidomics, PPAR signaling, adipocytokine signaling, glycerophospholipids, arachidonic acid, poultry science, hepatic steatosis